By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Pressure BioSciences has issued a call notice to holders of its outstanding warrants, the firm said in a filing with the US Securities and Exchange Commission today.

The firm said that each outstanding warrant will continue to be exercisable for preferred stock at an exercise price of $12.50 per share until the close of business on April 27, 2010. On April 28, 2010, any unexercised warrants will be terminated and no longer be exercisable, according to the company.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.